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Abstract
Background: Pluripotent embryonic stem cells (ESCs) have the unique ability to differentiate into every cell type
and to self-renew. These characteristics correlate with a distinct nuclear architecture, epigenetic signatures enriched for
active chromatin marks and hyperdynamic binding of structural chromatin proteins. Recently, several chromatin-related
proteins have been shown to regulate ESC pluripotency and/or differentiation, yet the role of the major heterochromatin
proteins in pluripotency is unknown.
Results: Here we identify Heterochromatin Protein 1β (HP1β) as an essential protein for proper differentiation,
and, unexpectedly, for the maintenance of pluripotency in ESCs. In pluripotent and differentiated cells HP1β is
differentially localized and differentially associated with chromatin. Deletion of HP1β, but not HP1α, in ESCs
provokes a loss of the morphological and proliferative characteristics of embryonic pluripotent cells, reduces
expression of pluripotency factors and causes aberrant differentiation. However, in differentiated cells, loss of
HP1β has the opposite effect, perturbing maintenance of the differentiation state and facilitating reprogramming to
an induced pluripotent state. Microscopy, biochemical fractionation and chromatin immunoprecipitation reveal a
diffuse nucleoplasmic distribution, weak association with chromatin and high expression levels for HP1β in ESCs. The
minor fraction of HP1β that is chromatin-bound in ESCs is enriched within exons, unlike the situation in differentiated
cells, where it binds heterochromatic satellite repeats and chromocenters.
Conclusions: We demonstrate an unexpected duality in the role of HP1β: it is essential in ESCs for maintaining
pluripotency, while it is required for proper differentiation in differentiated cells. Thus, HP1β function both
depends on, and regulates, the pluripotent state.
Background
Embryonic stem cells (ESCs), derived from the blastocyst-
stage embryo, are capable of generating all cell types of
the mammalian body (pluripotency) and of maintaining
the capacity for indefinite self-renewal without comprom-
ising their genomic integrity. This unique duality makes
them an attractive system for potential regenerative medi-
cine and cell therapies, but also for differentiation studies
in vitro and for modeling diseases. Their potential to form
embryonic cell types suggests that they have unique and
flexible epigenetic features and chromatin organization,
two features that have attracted considerable attention in
recent years [1–4].
Indeed, chromatin proteins were shown to be more
dynamically associated with chromatin in ESCs than in
differentiated cells [5, 6]. In addition, the nuclear lamina
protein lamin A/C (LMNA), which is barely detectable in
undifferentiated ESCs, is partly responsible for the re-
striction of chromatin plasticity during early differenti-
ation [5]. Chromatin modifiers, such as the histone H3
lysine 9 (H3K9) methyltransferase G9a, histone deace-
tylases, and chromatin remodelers (e.g., CHD1 and
SMARCD1) [5, 7–9], work together with lamin A/C to
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reduce nuclear plasticity. The genomes of ESCs also have
low levels of DNA methylation, particularly when the cells
are held in an undifferentiated ‘naïve’ state resembling the
inner cell mass [10, 11]. Consistently, pluripotent cells are
enriched for histone modifications associated with active
chromatin, and tend to be depleted for heterochromatin-
associated modifications, such as H3K9me3 [12–15]. Fi-
nally, we note that the undifferentiated ESC nucleus itself
shows less spatial organization than in differentiated cells.
For instance, condensed heterochromatin, which can be
observed by both light and electron microscopy, is less
frequently observed [16–18], and Heterochromatin
Protein 1 (HP1)α-enriched heterochromatin foci are
less compact and less numerous in ESCs [2, 13].
In mammals, the HP1 family includes three protein iso-
forms, HP1α (CBX5), HP1β (CBX1), and HP1γ (CBX3),
encoded by the genes Cbx5, Cbx1 and Cbx3, respectively.
HP1 proteins were originally identified in Drosophila as
structural proteins of heterochromatin and were shown to
be important regulators of heterochromatin-mediated
gene silencing [19, 20]. Later, the functions of HP1 pro-
teins were extended to include additional cellular pro-
cesses, such as transcriptional activation and elongation,
sister chromatid cohesion, chromosome segregation,
telomere maintenance, DNA repair, and RNA splicing
[21–27]. It is not known how these activities are distrib-
uted among the different higher eukaryotic HP1 variants.
All HP1 proteins contain two conserved domains, the
chromo-domain and the chromoshadow domain, sepa-
rated by a less structured hinge region. The chromo-
domain can recognize and bind the H3K9me2/me3
histone marks, which are frequently associated with
transcriptional repression [28, 29]. The chromoshadow
domain is required for dimerization and interaction
with other proteins that share a PXVXL motif [30]. As
mentioned above, HP1 isoforms have both overlapping
and distinct cellular functions, and their subcellular lo-
calizations are dissimilar in some cells. Specifically,
mammalian HP1α and HP1β primarily associate with
dense heterochromatic and silenced genomic regions in
differentiated cells, while HP1γ mainly localizes to euchro-
matic regions, often being associated with transcription-
ally active regions [31–33]. HP1 isoform functions are not
interchangeable, given that the inactivation of HP1β in
mice leads to a defective development of neuromuscular
junctions and cerebral cortex as well as perinatal lethality,
despite the presence of HP1α and HP1γ [34]. However,
little is known about how the different isoforms are
regulated.
As mentioned above, a growing number of chromatin-
related factors are implicated in either the maintenance of
pluripotency or the differentiation of ESCs. Examples in-
clude chromatin remodeling proteins [8, 35–37], histone
modifying enzymes [38–44], histone variants [45–50], and
HP1γ [15]. Reducing HP1γ levels in ESCs under differen-
tiating conditions was shown to enhance differentiation,
and to improve the reprogramming of somatic cells into
induced pluripotent stem cells (iPSCs) [15, 51]. Here we
show that another member of the heterochromatin pro-
tein family, HP1β, is necessary to maintain proper differ-
entiation in differentiated cells, but surprisingly, it is also
necessary to maintain pluripotency in ESCs in normal
conditions, unlike HP1γ. This is not the case for HP1α. In
addition, unlike somatic and differentiated cells, HP1β
does not localize primarily to heterochromatic chromo-
centers in ESCs, but rather assumes a diffuse nuclear
localization. It is highly expressed in ESCs, and on
chromatin it is enriched in genic, mostly exonic re-
gions. Importantly, loss of HP1β results in premature,
spontaneous differentiation along with misregulation of
several pluripotency factors and developmental genes.
The fact that HP1β exhibits two distinct nuclear locali-
zations and plays nearly opposing roles at two states of
differentiation (pluripotent versus differentiated cells)
argues that a single HP1 protein can assume strikingly
distinct roles as a function of cell differentiation. This
significantly embellishes previous concepts of HP1
function, which assigned distinct localization and func-
tion to different HP1 isotypes.
Results and discussion
HP1β, but not HP1α, is essential to maintain pluripotency
and cell proliferation in ESCs
In order to determine whether HP1α and/or HP1β iso-
forms have any role in stem cell pluripotency and early
differentiation, we took advantage of the recently gener-
ated HP1α−/− and HP1β−/− knockout (KO) mice and of
the derived pluripotent ESCs, the differentiated embryoid
bodies (EBs), and the mouse embryonic fibroblast (MEF)
cells from these KO strains [34, 52]. To explore whether
HP1α or HP1β has a specific function in pluripotent/un-
differentiated cells, we analyzed the morphology of
HP1α−/− and HP1β−/− ESCs, their cell growth, and differ-
entiation potential compared with their wild-type (WT)
counterparts at identical passages under identical condi-
tions. To validate the KO clones and the specificity of the
HP1α and HP1β antibodies, we verified the absence of the
specific HP1 protein in the appropriate cell line, using
immunofluorescence (IF) and western blots (Figure S1a, b
in Additional file 1). As we cultured the KO ESCs, we
noticed unexpectedly that whereas WT and HP1α−/−
ESCs displayed normal colony morphology, most of the
HP1β−/− ESCs did not form the usual compact three-
dimensional colonies. They tended instead either to differ-
entiate spontaneously or to remain very small (Fig. 1a).
This was observed both in the presence of leukemia in-
hibitory factor (LIF), which maintains ESCs in their undif-
ferentiated state, and in its absence, where the effect was
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more pronounced. We also observed that the HP1β−/−
ESCs differentiated faster than WT and/or HP1α−/− ESCs
upon LIF depletion (Fig. 1a, lower panel). The same was
true when differentiation was induced by retinoic acid
(RA; data not shown). Finally and importantly, HP1β−/−
but not HP1α−/− ESCs displayed significantly reduced
growth rates (Fig. 1b), indicating a reduced capacity for
self-renewal.
We next tested the differentiation potential of HP1α−/−
and HP1β−/− ESCs. To this end, we performed a teratoma
assay, which involves injecting HP1α−/−, HP1β−/−, and
WT ESCs under the skin of SCID mice. Three weeks later
the resulting teratomas were analyzed by histology. We
detected increased neuroectoderm formation in terato-
mas derived from HP1β−/− ESCs, although all three
germ layers were present in all the teratomas of all cell
lines tested (Fig. 1c). To validate this observation, we
performed directed differentiation of WT and HP1β−/−
ESCs into neuroectoderm in vitro. HP1β−/− ESCs displayed
accelerated neuronal differentiation, as judged by morph-
ology and increased Tuj1-positive cells (Fig. 1d). Together,
these results argue that the absence of HP1β in ESCs com-
promises the maintenance of pluripotency and cell prolifer-
ation, and increases neuronal differentiation both in vitro
and in vivo. This suggests that HP1β negatively regulates
neuronal differentiation in pluripotent cells and is thereby
required to maintain pluripotency. We confirmed the re-
sults for the KO ESCs by RNA interference for HP1β
which, similarly, led to premature differentiation (Figure
S2b in Additional file 2).
HP1β is 100 % conserved between mouse and human,
and mouse HP1β and HP1α are 63 % identical (and 79 %
similar). It was of interest, therefore, to examine the ef-
fects of HP1β loss on overall chromatin organization.
First, visualizing pericentromeric heterochromatin by
DAPI, we note that the absence of HP1β had no sig-
nificant impact on the global structure of pericentro-
meric heterochromatin domains in ESCs (Figure S1c in
Fig. 1 HP1β is essential to maintain pluripotency and cell proliferation in ESCs. a Premature differentiation of HP1β−/− ESCs. Shown are WT (left),
HP1α−/− (middle), and HP1β−/− (right) ESCs grown in the presence (top) or absence (bottom) of LIF. WT and HP1α−/− ESCs maintain normal growth and
colony morphology whereas the HP1β−/− ESCs tend to spontaneously differentiate and form flat colonies (red outline). Scale bar = 200 μm. b Cell
proliferation assay. Proliferation rate is reduced in HP1β−/− ESCs, but unaltered in HP1α−/− ESCs. c Histological analyses of teratomas formed by WT,
HP1α−/− and HP1β−/−ESCs. The three germ layers were observed in all teratomas but neuroectodermal differentiation (dark blue) appeared particularly
enriched in the HP1β−/− cells. Scale bar = 200 μm. d Accelerated neuronal differentiation in directed differentiation of HP1β−/− ESCs. Neuronal
progenitor cells (NPCs) from WT and HP1β−/− ESCs were immunostained with Tuj1. Scale bar = 25 μm
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Additional file 1), nor did loss of HP1α (Figure S1c in
Additional file 1). In addition, H3K9me3 staining of peri-
centromeric heterochromatic foci, as shown by the over-
lap with the DAPI staining in MEFs and ESCs, was also
not altered in HP1α−/− and HP1β−/− ESCs compared with
their WT counterparts (Figure S1c in Additional file 1).
This observation is in line with previous reports in dif-
ferentiated 3T3 mouse fibroblasts [53].
Using a more quantitative approach, we monitored
fluorescence recovery after photobleaching (FRAP) for
H1-GFP, as an indicator for chromatin plasticity [5]. This
is used to monitor the impact of HP1β depletion on gen-
eral chromatin proteins, as previously reported for CHD1
in euchromatic regions [8]. However, H1 protein dynamics
in WT and HP1β−/− ESCs were not significantly different
(Figure S1d in Additional file 1). Indeed, as described
below, HP1β itself is relatively poorly associated with
chromatin in ESCs (see Fig. 7). Finally, to test whether the
reduced capacity for self-renewal of HP1β−/− ESCs (Fig. 1b)
could be explained by defects in chromosome segregation
during mitosis, we monitored metaphase and anaphase
cells in HP1α−/−, HP1β−/− and WT ESCs (Figure S2a in
Additional file 2). No defects, such as DNA bridges, were
detected in any of the anaphase ESCs, although H3K9me3
has been described to be important for chromosome seg-
regation [29]. In addition, H3K9me3 staining in these
cells was perfectly localized mainly at pericentromeric
regions, as expected (Figure S2a in Additional file 2).
This suggests that chromosome segregation can occur
normally in HP1β−/− ESCs.
HP1β regulates developmental genes and pluripotency
factors in ESCs
Given the strong phenotypic effect of HP1β deletion on
pluripotency, and the absence of change in chromatin
organization, we next looked for effects on the level of
gene expression. Using Affymetrix whole transcriptome
microarrays (GSE65121), we analyzed transcription pro-
files of WT, HP1α−/− and HP1β−/− ESCs in duplicates,
and after EB differentiation for 7 days. EBs are known to
undergo non-directed differentiation and cell specifica-
tion into the three germ lineages (endoderm, ectoderm,
and mesoderm). To ensure that neither MEFs nor spon-
taneously differentiating cells contaminated our ESC
preparations, we sorted the pluripotent SSEA1-positive
cells from all ESC types using magnetic beads and a
column-based method. This is particularly important in
the case of HP1β−/− ESCs, since, as noted above, these
cells tend to spontaneously differentiate. Using a thresh-
old of 1.5-fold change in mRNA level (corresponding to
p < 0.05; Figure S3a in Additional file 3) comparing mu-
tant and WT ESCs and EBs, we found that the loss of
HP1β resulted in the misregulation of 495 and 1054
genes in ESCs and EBs, respectively. The loss of HP1α,
on the other hand, had a more subtle effect in both ESCs
and EBs, with 53 and 627 genes altered, respectively
(Fig. 2a, right). When a stringent cutoff of 2.5-fold in tran-
scription level was used (corresponding to p < 0.005;
Figure S3a in Additional file 3), only one gene passed the
threshold in the HP1α−/− ESCs, and 97 genes did in the
corresponding EBs. In contrast, the HP1β−/− ESCs had 34
genes in the undifferentiated ESCs and 201 in the corre-
sponding EBs that were at least 2.5-fold misregulated
(Fig. 2a, left). Changes in gene expression were validated
in both ESCs and EBs using quantitative RT-PCR (qRT-
PCR) for several genes (r2 > 0.8 between the two methods;
Figure S3b, c in Additional file 3). We conclude that HP1β
has a far more significant effect on gene expression in
both ESCs and EBs than HP1α.
We next examined the misregulation of established
lineage markers in ESCs and found that, once again, HP1α
deficiency had a relatively mild effect, with none of the se-
lected markers showing a significant change (Fig. 2b). In
contrast, depletion of HP1β resulted in significant changes
in the expression of genes from all lineages examined, in-
cluding endoderm, mesoderm, ectoderm, and trophoecto-
derm (Eomes). The most pronounced effect was again in
neuroectoderm lineage markers, where significant overex-
pression of a related set of genes was detected (Fig. 2b).
This correlates well with the changes observed in protein
levels of neuroectodermal markers and with the effect of
HP1β deletion on teratoma formation (Fig. 1c, d). Consist-
ently, Gene Ontology (GO) analysis for the genes upregu-
lated >2.5-fold in the HP1β−/− ESCs revealed a significant
enrichment in categories reflecting neuronal differenti-
ation and cell proliferation (Fig. 2c). In contrast, the effect
of HP1α deletion was again insignificant, even when the
more relaxed threshold of 1.5-fold was used. Importantly,
loss of HP1β in ESCs also led to a significant downregula-
tion of key pluripotency factors (Fig. 2d), a fact that may
explain the partial loss of pluripotency characteristics of
those cells (morphology, growth rate, etc.). This is unlike
the loss of HP1α (Fig. 2d) and unlike depletion of HP1γ,
which show normal expression of pluripotency markers
[15, 51]. In summary, we find that the loss of HP1β in
ESCs downregulates the expression of pluripotency factors
and skews the expression of developmental genes. This
correlates with premature ESC differentiation, particularly
along the neuroectodermal lineage. Such effects are
unique to HP1β.
To determine whether HP1β KO also affects later stages
of differentiation, we compared the transcriptional profiles
from 7-day-old EBs originating from WT, HP1α−/− and
HP1β−/− ESCs. As in earlier stages, loss of HP1α had a
mild effect on gene expression, and it subtly, but signifi-
cantly, altered lineage markers of the three germ layers.
Loss of HP1β, on the other hand, had a particularly robust
effect on mesodermal lineage markers. For instance, loss
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of HP1β led to the downregulation of Bmp2, Bmp4, Des,
and Fgf15 (Fig. 3a). GO analysis on the altered genes
(using a threshold of 2.5-fold) in HP1β−/− EBs indicated
strong effects on heart and muscle development (Fig. 3b),
consistent with mesodermal differentiation defects. This is
consistent with the fact that modulation of the HP1β
protein level has been found to impair MyoD target gene
expression and muscle terminal differentiation [33].
Therefore, whereas the differentiation of HP1β−/− ESCs
was skewed towards neuroectoderm, HP1β−/− EBs were
skewed away from proper mesoderm formation. Interest-
ingly, a relatively high number of actin, myosin, and re-
lated proteins, which we found as interacting partners of
HP1β in differentiated cells (see below and Fig. 4), were
found to be both up- and downregulated (GO category
“actomyosin structural organization”) in the HP1β KO
cells (Fig. 3b). Finally, several pluripotency genes, in-
cluding Nanog, Oct4, Esrrb, Dppa2, Dppa5a, and Stat3
failed to be correctly downregulated in the differenti-
ated HP1β−/− EBs compared with WT EBs (Fig. 3c). It
is important to point out that pluripotency factors are
downregulated in HP1β−/− ESCs but upregulated in the
differentiating HP1β−/− EBs. This result, together with
the distinct effects that HP1β elimination has on ESCs
and EBs, suggests that HP1β influences gene expression
in opposite directions — or at the very least triggers
distinct pathways of gene control — in pluripotent ver-
sus differentiated cells.
HP1β has different interacting partners in pluripotent and
differentiated cells
Because HP1β has very distinct and contrasting effects
on gene regulation in pluripotent versus differentiated
cells, we checked whether HP1β is associated with
different protein complexes in the two cell states. To
examine HP1β’s interacting partners in pluripotent and
differentiated cells, we immunoprecipitated the en-
dogenous HP1β from both ESC and MEF extracts, and
used liquid chromatography-tandem mass spectrometry
(LC-MS/MS) to examine co-precipitating proteins. This
allowed us to avoid potential artifacts due to overexpres-
sion or the addition of tags. Experiments were performed
in two biological replicates and non-specific interac-
tions were eliminated using anti-green fluorescent pro-
tein (anti-GFP) as a negative control. Several HP1β
interaction partners were common to both ESCs and
MEFs, including hnRNPH2, hnRNPA0, Rundc2a, Eif4e-
nif1 and histone H2B (Fig. 4a; Additional file 4). How-
ever, the large majority of HP1β’s interaction partners
differed between the two cell types (Fig. 4a), suggesting
that the recovery is not a product of contamination.
Moreover, the number of identified HP1β interacting part-
ners overall was considerably lower in ESCs than in MEFs
(30 versus 105 proteins; Additional file 4). Whereas it is
impossible to infer function from simple immunoprecipi-
tation, the fact that we recovered different sets of interact-
ing partners is consistent with a distinct function for
HP1β in differentiated cells.
HP1β restricts reprogramming into iPSCs
The distinct effects on gene expression and the differ-
ent interaction partners of HP1β in ESCs and MEFs
prompted us to test its potential involvement in som-
atic cell reprogramming to iPSCs. To this end, we gen-
erated iPSC colonies from WT and HP1β KO MEFs by
lentiviral infection expressing the four reprogramming
factors Oct4, Sox2, Klf4, and cMyc. HP1β KO MEFs
displayed increased reprogramming efficiency com-
pared with WT MEFs as judged by the number of iPSC
colonies generated after 12 days of reprogramming in
identical conditions by alkaline phosphatase staining
(Fig. 4b). This again suggested that, like HP1γ [15],
HP1β helps maintain a proper differentiation state in
WT differentiated cells by inhibiting efficient repro-
gramming. Indeed, heterochromatin reorganization was
found to be one of the first steps in the rearrangement
of chromatin from a somatic-like to a pluripotent-like
state during the reprogramming process [14].
Importantly, and consistent with the phenotypes we
observed in HP1β−/− ESCs, fully reprogrammed HP1β
KO iPSCs exhibit similar properties to those of HP1β−/−
ESCs. They tend to differentiate spontaneously and rap-
idly, especially in the absence of a feeder layer, losing their
compact morphology after several passages (Fig. 4c). In
(See figure on previous page.)
Fig. 2 HP1β regulates developmental genes and pluripotency factors in ESCs. a Number of misregulated genes in HP1α−/− (empty bars) and HP1β−/−
(filled bars) ESCs and EBs compared with WT cells at a 0.005 (left) or 0.05 (right, shaded) confidence level, which correspond to 2.5- and 1.5-fold change,
respectively. b Expression fold change in HP1α−/− (empty bars) and HP1β−/− (filled bars) ESCs compared with WT cells of developmental marker genes
representative of endoderm (top), mesoderm (middle) and ectoderm (bottom). The shaded grey area represents fold changes which are not statistically
significant. c Gene Ontology analysis of biological processes affected in the HP1β−/− ESCs. Biological processes where bars in the graph go to the left
of zero (here, only “regulation of cell proliferation”) are those affected significantly by genes downregulated in HP1β−/− ESCs, whereas those where
bars in the graph go to the right of zero are those significantly affected by genes upregulated in HP1β−/− ESCs. The actual p values are shown for each
biological process. The list of the misregulated genes was analyzed according to their functional annotation and the biological processes they belong
using the Database for Annotation, Visualization and Integrated Discovery (DAVID). d Expression fold change in HP1α−/− (empty bars) and HP1β−/−
(filled bars) ESCs compared with WT cells of key pluripotency factors. The grey area represents fold changes which are not statistically significant
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Fig. 3 HP1β is important for mesodermal differentiation of embryoid bodies. a Relative fold change of developmental genes of the three germ
layers in EBs derived from HP1α KO ESCs (empty bars) and EBs derived from HP1β KO ESCs (filled bars). Upregulated genes are depicted above the
line at zero, and downregulated genes below it. The grey area represents fold changes which are not statistically significant. b GO analysis of
biological processes affected in HP1β KO EBs. Biological processes where the bars in the graph go to the left of zero are those affected significantly by
genes downregulated in HP1β−/− EBs, whereas the those where the bars go to the right of zero are those significantly affected by genes upregulated
in HP1β−/− EBs. The actual p values are shown for each biological process. c Relative fold change of key pluripotent factors for EBs derived from HP1β
KO ESCs. Upregulated genes are depicted above the line at zero and downregulated genes below it. The grey area represents fold changes which are
not statistically significant
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contrast, iPSC colonies generated from HP1α KO MEFs
were morphologically indistinguishable from WT iPSC
colonies and HP1α KO ESCs (Fig. 4c). Taken together, our
findings confirm that pluripotent cells such as ESCs and
iPSCs that lack HP1β tend to differentiate spontaneously.
On the other hand, HP1β−/− differentiated cells could not
maintain a proper differentiation state (EBs) and repro-
grammed into iPSCs more easily than WT cells (MEFs)
(Fig. 4d). This contrasting behavior argues that HP1β has
distinct roles at different stages of differentiation. HP1β
maintains pluripotency in ESCs, while in differentiated
cells it helps maintain the differentiated state.
Fig. 4 HP1β has different interacting partners and functions in pluripotent and differentiated cells. a The number of HP1β interacting partners
identified by liquid chromatography-tandem mass spectrometry in MEFs, and in ESCs excluding hits found in control samples. Hits identified
in both cell types are indicated. b Reprogramming experiments. Alkaline phosphatase (AP) staining of iPSCs induced from WT MEFs and HP1β
KO MEFs after 12 days of reprogramming in identical conditions. c Phase contrast images of WT (left), HP1α KO (middle) and HP1β KO (right)
iPSC colonies cultured in standard conditions at passage 1 (top) or passage 6 (bottom) after isolation from the reprogramming plate. HP1β KO
iPSCs gave rise to flat and spontaneously differentiating cells (red outline), similar to HP1β KO ESCs. Scale bar = 200 μm. d Graphic summary of
HP1β localization and function in pluripotent versus differentiated cells. In WT cells, HP1β is highly expressed and diffuse in ESC and iPSC nuclei whereas
it decreases in differentiated cells and associates mostly with pericentric heterochromatin. HP1β KO pluripotent cells do not maintain a proper pluripotent
state and tend to differentiate spontaneously; differentiating cells lacking HP1β display skewed differentiation, and reprogramming is facilitated in the
absence of HP1β
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HP1β is highly expressed and diffuse in nuclei of
pluripotent cells
We next asked how this can be achieved. Is there dissimi-
lar expression and/or localization of HP1β in the different
cell states? Indeed, by indirect immunofluorescence [14],
we scored an approximately threefold higher expression
level of HP1β in pluripotent nuclei of mouse Rr5 iPSCs
[14] and R1 ESCs over that in MEFs (Fig. 5a, b). The Rr5
iPSC line contains both fully and partially reprogrammed
iPSCs with otherwise similar properties (i.e., morphology,
size, proliferation rate, nuclear volume) [14], conveniently
enabling us to compare these two cell populations in the
same field of view using Nanog staining as a marker of
pluripotency. Only the “fully” reprogrammed and pluripo-
tent Rr5 iPSCs showed high levels of HP1β, arguing that
elevated HP1β levels are truly linked to the pluripotent
state, and do not simply reflect proliferation rate or cell
size. The MEF feeder layer (some of which are marked by
asterisks in Fig. 5), which is used to maintain the undiffer-
entiated state of pluripotent cells, provided us with an
additional internal control, in the same image field for
HP1β staining. We also confirmed that HP1β is present at
higher levels in ESCs than in MEFs by western blotting
extracts from mouse ESCs and MEFs (Figure S4a, b in
Additional file 5 and Fig. 7c). Total levels of HP1β normal-
ized to the amount of histone H3 shows an enrichment in
ESCs of about threefold compared with MEFs (Figure S4b
in Additional file 5), consistent with fluorescence intensity.
Finally, we observed a slight, but reproducible, drop in
HP1β levels after 7 days of ESC differentiation towards
EBs (Figure S4c in Additional file 5).
We compared our results with previous reports and
with publicly available gene expression datasets [54, 55]
to ensure that this variation is broadly observed, even at
the transcriptional level. Consistent with our findings,
the Amazonia dataset [56] shows higher HP1β expres-
sion levels in human pluripotent cells compared with all
other differentiated cell types (Figure S4d in Additional
file 5). In previous datasets, HP1β had a threefold higher
level in undifferentiated mouse ESCs over 7-day-old
neuronal progenitor cells (NPCs) derived from those
ESCs by in vitro differentiation [18]. HP1γ also displayed
approximately threefold higher levels in ESCs compared
with NPCs, in contrast to HP1α, which was only ~1.5
fold higher in the undifferentiated cells. The fact that
HP1β and HP1γ levels decrease more sharply than
HP1α levels upon differentiation supports the results we
obtained by immunofluorescence on pluripotent and dif-
ferentiated cells (Figs. 5d-e and 7e for HP1γ; and [14]
for HP1α).
Akin to other chromatin proteins, the localization of
the HP1 isoforms may be more important than their ab-
solute levels. In support of this, we found that HP1β has
a diffuse nucleoplasmic staining pattern in the nuclei of
iPSCs and ESCs, in stark contrast to the characteristic
heterochromatic foci found in the nuclei of differentiated
MEFs (Fig. 5a, c; see Figure S6a in Additional file 6 for
shorter exposure). This phenomenon was also true for
HP1γ (Fig. 5d, e), but was not the case for HP1α.
Whereas HP1α is somewhat diffuse in the nuclei of
pluripotent cells, it also clearly labels heterochromatic
foci [6, 14]. We quantified these differences by counting
the average number of HP1β-positive foci in each cell
type. We scored, on average, 12.2 ± 2.4 HP1β foci per
nucleus in MEFs and 0.1 ± 0.4 in either fully repro-
grammed iPSCs or ESCs (Fig. 5c). These observations
were reproducible under different conditions, and are
consistent with previous studies which showed fewer
HP1β heterochromatic foci in E14 mouse ESC line (4 foci
per ESC) than in a more differentiated state (11 HP1β
foci per cell [57]). We note that the E14 ESCs displayed
a lower level of histone acetylation and a diminished
ability to reprogram MEFs by cell fusion than the R1
ESCs used above [58]. Consistent with the stronger plur-
ipotency character of our R1 ESCs over E14 cells, we see
that HP1β assumes a completely diffuse pattern in the
nucleoplasm of R1 ESCs, while it was partially accumu-
lated at heterochromatin foci in E14 ESCs (Figure S6b in
Additional file 6).
A final confirmation that HP1β changes localization
during differentiation came from the use of an endogen-
ously tagged fluorescent protein library (our own unpub-
lished resource), in which HP1β is endogenously fused
with the mCherry fluorescent protein. By scoring HP1β
localization in living cells we can avoid potential artifacts
of fixation or overexpression. Spinning disk time lapse
imaging of ESC differentiation showed that HP1β has a
diffuse pattern in undifferentiated cells, which transi-
tions to HP1β focus accumulation. This occurred
within 24–36 hours, at which point all cells displayed
some degree of HP1β foci (≥1–2 foci per cell; Fig. 5f;
Additional file 7). Taken together, we conclude that
HP1β is more highly expressed and has a diffuse sub-
nuclear localization in pluripotent stem cells, whereas
it becomes heterochromatin-enriched in differentiated
cells, consistent with the different roles it has in the
two cell states.
HP1β is enriched within genes in pluripotent cells
In order to confirm these imaging results, we investigated
the distribution of HP1β genome-wide using ChIP-Seq.
ChIP-Seq analysis in ESCs showed that HP1β is signifi-
cantly enriched in genes, especially within exons (p < 10−4,
hypergeometric test; Fig. 6a; [GEO:GSE64946]). Moreover,
HP1β is largely depleted from intergenic regions in ESCs,
which would normally show enrichment for heterochro-
matin. Moreover, HP1β was largely depleted from prox-
imal promoters (Fig. 6a) and transcription start sites
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(Fig. 6b), yet showed a clear enrichment gradient that in-
creased from introns to exons: indeed, HP1β is more
strongly enriched on exons than on introns (Fig. 6c–e).
This preferential association of HP1β with exons is con-
sistent with a unique role in pluripotent cells, and suggests
a potential role in exon recognition, that may coincide
Fig. 5 HP1β is highly expressed and diffuse in nuclei of pluripotent cells. a Confocal images of MEFs (top), R1 ESCs (middle) and Rr5 iPSCs
(bottom) immunostained for Nanog (green, middle), HP1β (red, right) and counterstained with DAPI (blue, left). Asterisks indicate examples of MEFs
used as a feeder layer in the culture of the pluripotent cells. b Quantification of the fluorescence intensities of Nanog (green bars) and HP1β (red
bars) for the three cell types (n≥ 26). Nanog is used as a marker for pluripotent cells; the fluorescence intensity of the background intensity was
subtracted. c Number of HP1β foci in the different cell types. Error bars in (b) and (c) represent standard error of the mean. d Confocal images of
R1 ESCs immunostained for Nanog (green, middle), HP1γ (red, right) and counterstained with DAPI (blue, left). e Confocal images of Rr5 iPSCs
immunostained for HP1γ (red) and Nanog (inset, green). Asterisks indicate feeder layer MEF cells in (d) and (e). Scale bars for (a–e) = 15 μm. f Time
lapse spinning disk confocal images of ESCs expressing the endogenous HP1β fused to mCherry induced to differentiate with 1 μM of retinoic
acid (RA) for 40 hours (see also Additional file 7 for a video)
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with histones bearing H3K36me3 [59]. Interestingly, ‘alter-
native splicing’ was the most highly enriched category in
GO analysis performed for the HP1β-bound genes (Figure
S5a in Additional file 8). These correlations suggest a
potential role for HP1β in exon recognition and/or pre-
mRNA processing in ESCs. This observation is in line with
a recent study that showed that HP1β regulates the alter-
native splicing of a subset of genes in a DNA methylation-
Fig. 6 HP1β is enriched within genes in pluripotent cells. a ChIP-Seq enrichment scores for HP1β in the indicated genomic regions. HP1β is
highly enriched within exons (*** p < 0.0001, * p < 0.005, permutation test). Note promoter depletion. UTR untranslated region. b Average HP1β
distribution (over all genes) around the transcription start site (TSS). c HP1β distribution within an average intron. Introns are overall enriched for
HP1β but depleted when compared with exons. d HP1β distribution within an average exon. e HP1β is localized in gene bodies and exons.
Examples of HP1β ChIP-Seq signal in genes and exons. RefSeq gene annotation is shown in the top row; below, HP1β ChIP-Seq read signals are
shown in red and input read signals are shown in blue. MACS peaks are shown in the bottom row
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dependent manner [60], which is thought to be achieved
by the recruitment of splicing factors to DNA methylated
genes through HP1β [60].
Since HP1β is not known to bind methylated H3K36,
we next compared the HP1β ChIP-Seq data with other
existing genome-wide datasets in ESCs (Figure S5b in
Additional file 8). We found significant correlation of
HP1β-bound loci (p < < 10−16) with H3K36me2/me3,
which is also enriched within exons [59, 61], as well as
with H3K9me3 (p < < 10−16). This suggests that HP1β,
while largely euchromatic and exonic in ESCs, may also
be associated in some regions with H3K9me3.
To understand if the changes in gene expression in the
HP1β−/− ESCs resulted from transcriptional regulation by
HP1β or from post-transcriptional regulation through
HP1β, we tested the correlation between HP1β binding to
the genome and the changes in expression level of the cor-
responding genes or promoter regions. Comparing the list
of the misregulated genes (>1.5-fold) in the HP1β−/− ESCs
with the list of the promoters or gene bodies directly
bound by HP1β (ChIP-Seq data), we found that promoter
regions bound by HP1β do not correlate significantly with
misregulation of the adjacent genes (hypergeometric p
value > 0.9; Figure S5c in Additional file 8). The HP1β-
bound exons/gene bodies selected with a mild threshold
(p < 0.01) also had no significant correlation with upregu-
lated transcripts in the HP1β KO ESC samples, whereas a
slight correlation was found with downregulation. When a
more stringent threshold was used for the HP1β-bound
genes (p < 0.001), a higher significance level was observed
for a group of 15 genes that were clearly downregulated in
HP1β−/− ESCs (Figure S5c–e in Additional file 8), suggest-
ing that HP1β could potentially upregulate the transcrip-
tion of this subset of genes in WT ESCs. Nonetheless,
since the majority (>97 %) of HP1β-bound genes in ESCs
had no change in their expression level in HP1β−/−
ESCs, it appears that, in pluripotent ESCs, HP1β by it-
self probably does not act principally by modulating
transcription. Supporting this view, we found that the
genes that are misregulated in HP1β KO ESCs and that
are included in biological process categories such as
“regulation of cell proliferation” or “regulation of cell
development” (Fig. 2c; e.g., Inpp5D, Ifitm3, Nefl, Nefm,
Tnfrsf12a) are not genes or promoter regions bound by
HP1β in ESCs. Nor are pluripotency factors such as
Nanog or Klf4 downregulated in HP1β KO ESCs (see
below). In addition, none of the genes (listed in Figure
S5e in Additional file 8) bound by HP1β and misregu-
lated in HP1β KO ESCs seem a priori able to explain
all the phenotypes observed in HP1β KO ESCs. Alter-
natively, HP1β may work by modulating mRNA pro-
cessing or export or may serve to maintain a chromatin
state that only affects gene expression at a later point
in development.
HP1β binds chromatin in a distinct manner in pluripotent
and differentiated cells
We next asked whether the more diffuse distribution of
HP1β found in ESCs versus differentiated cells reflects a
different mode of binding to chromatin. To that end, we
first co-stained MEFs and ESCs with the heterochroma-
tin markers H3K9me3 and HP1β. Whereas HP1β almost
completely overlapped with H3K9me3 in MEFs, consist-
ent with recognition of H3K9me3 by its chromodomain,
it did not co-localize with bright H3K9me3 foci in ESCs
(Fig. 7a). In the case of HP1α, a major overlap with the
H3K9me3 foci was scored in both ESCs and differenti-
ated cells [6]. Therefore, we suggest that the correlation
of HP1β with H3K9me3 by ChIP-Seq in ESCs probably
does not represent HP1β association with H3K9me3-
containing chromocenters, but rather recognition of this
modification at other loci. On the other hand, in the
somewhat less pluripotent E14 ESCs, the few HP1β foci
that we observed did co-localize largely with H3K9me3
heterochromatin (Figure S6c in Additional file 6).
We next performed ChIP-qPCR to test the association
of HP1β with major satellite repeats in ESCs. The major
satellite is the main sequence element in heterochro-
matic pericentromeric regions and these generally map
to the chromocenters where HP1β binds in differenti-
ated cells [53, 62]. Unlike the situation in MEFs, HP1β
was not highly enriched on major satellite repeats in
pluripotent ESCs (Fig. 7b). These results are consistent
with a recent study in which HP1β was shown to be only
moderately enriched at pericentromeric regions in ESCs,
while HP1α was strongly enriched at these sites, as mon-
itored by a quantitative locus purification method [63].
The large absence of HP1β on major satellites in pluri-
potent ESCs compared with MEFs is consistent and re-
inforces the almost complete absence of pericentromeric
foci enriched with HP1β in ESCs.
In order to measure the association of HP1β with
chromatin in differentiated and undifferentiated cells
biochemically, we fractionated MEFs and ESCs into cyto-
plasmic (S1), nucleoplasmic/chromatin unbound (S3) and
chromatin-bound (P3) fractions, and analyzed HP1β levels
in each fraction using immunoblots. Interestingly, HP1β
was highly enriched in the nucleoplasmic fraction of ESCs,
and was only weakly associated with the chromatin frac-
tion, whereas in the differentiated MEFs, HP1β was more
enriched in the chromatin-bound fraction (Fig. 7c, d).
We obtained similar results for HP1γ (Fig. 7e), which
also displayed a diffuse nuclear localization in pluripo-
tent ESCs (Fig. 5d, e). This is in contrast to HP1α distri-
bution, which largely overlaps with pericentromeric
heterochromatic foci at all stages of differentiation (data
not shown and [6]). Finally, to test whether HP1β and
HP1γ have redundant functions in ESCs, we knocked
down over 70 % of the level of HP1γ by small interfering
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RNA (siRNA) in the HP1β−/− ESCs (Figure S6d in
Additional file 6), and found that depletion of HP1γ led to
a slight (~18 %, p = 0.01) reduction in the proliferation
rate of WT cells (Figure S6e in Additional file 6) [15, 51],
yet there were no additive effects on cell growth and sur-
vival in the HP1β KO/HP1γ knock-down (Figure S6f in
Additional file 6).
Taken together, we conclude that, unlike the situation
in differentiated cells, HP1β does not associate predom-
inantly with chromatin in ESCs, does not localize to
pericentromeric H3K9me3 foci, and is not enriched on
major satellite repeats. Importantly, we show by ChIP-
Seq that HP1β in ESCs is enriched on exons over the
genome, even though this may represent a minor frac-
tion of total HP1β in ESCs, given that most HP1β is not
chromatin-bound. The distribution and expression levels
of HP1β and HP1γ are similar, yet loss of HP1β in ESCs
resulted in precocious differentiation in cultured ESCs,
and HP1β−/− embryos died perinatally [34], while deple-
tion of HP1γ affected cell growth and differentiation
only under certain conditions [51]. Thus, this dual and
opposing function in pluripotent and differentiated cells
Fig. 7 HP1β does not associate predominantly with chromatin in pluripotent cells. a No colocalization of HP1β with pericentromeric H3K9me3
foci in pluripotent cells. MEFs (left) and R1 ESCs (middle) were co-immunostained for DAPI (top), H3K9me3 (middle) and HP1β (bottom). Right panel:
an enlargement of the ESC colony shown in the box. Asterisks mark examples of feeder layer MEFs used for the culture of pluripotent cells. Scale
bars = 25 μm. b Chromatin immunoprecipitation (ChIP)-quantitative PCR for HP1β on major satellite repeats in MEFs and ESCs. HP1β is not enriched
on major satellite repeats in pluripotent cells. The SSC144 region was used as control. Error bars represent standard error of the mean. c HP1β
is predominantly nucleoplasmic/chromatin-unbound in pluripotent cells. Western blots for α-tubulin, HP1β and histone H3 in MEFs (left) and
R1 ESCs (right), fractionated to the cytoplasmic fraction (S1), nucleoplasmic (nuclear chromatin-unbound) fraction (S3), and chromatin-bound
fraction (P3). PonceauS protein staining in the histone range of the blot was used as a loading control (bottom). d HP1β levels in each
fraction were quantified from three independent experiments. Error bars represent standard error of the mean; a.u. arbitrary units. The
ratio of the nucleoplasmic fraction to the chromatin-bound fraction is indicated below for MEFs and ESCs. e Western blots for HP1γ in
MEFs and R1 ESCs, fractionated to the cytoplasmic fraction (S1), nucleoplasmic (nuclear chromatin-unbound) fraction (S3), and chromatin-bound
fraction (P3). Protein staining with PonceauS in the histone range of the blot was used as a loading control. The ratio of the nucleoplasmic fraction
to the chromatin-bound fraction is indicated below for both MEFs and ESCs
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appears to be unique to HP1β and is not shared redun-
dantly with HP1γ or HP1α.
Here we have reported unique characteristics and an
unexpected role for HP1β in mouse ESCs. Functionally,
we found that HP1β is required to maintain the undiffer-
entiated/pluripotent ESC state, given that HP1β depletion
in both ESCs and iPSCs resulted in precocious differenti-
ation. The differentiation was mostly towards neuronal
cell types. This is in line with the aberrant cerebral cortex
development phenotype observed in vivo in the HP1β−/−
mutant mice [34], which die around birth with defective
cerebral corticogenesis and reduced proliferation of neur-
onal precursors. Whereas HP1β−/− MEFs proliferate at a
similar rate to that of WT MEFs, HP1β−/− ESCs display
slower proliferation rates than WT or HP1α−/− ESCs, in
conjunction with other observations [64].
A meta-analysis of all available ChIP-Seq datasets in
ESCs [65] revealed that the HP1β promoter is bound by
Oct4, Nanog, Klf4, Esrrb, Nr5a2, and Sall4, which are all
factors of the pluripotency network. This may well ac-
count for the high levels of HP1β in ESCs. Indeed, a
knockdown of Oct4 in ESCs downregulated HP1β, while
knockdown of Nanog or Klf4 did not [66]. However, we
have made the intriguing finding that the depletion of
HP1β in ESCs leads to the downregulation of most of
the key pluripotency factors, including Nanog, Klf4, and
Esrrb, but not of Oct4 (Fig. 5d). This suggests that Oct4
acts upstream of HP1β, and may be responsible for the
high expression level of HP1β in ESCs. This in turn ap-
pears to contribute by regulating the other pluripotency
factors. Nonetheless, the effect of HP1β on the global
pluripotency gene expression signature does not appear
to be through direct transcriptional control. One pos-
sible mode of action is that the nucleoplasmic fraction
of HP1β stabilizes or potentiates selected long intergenic
non-coding RNAs (lincRNAs) that were shown to asso-
ciate with HP1β in ESCs and to regulate pluripotency
[67]. While this is possible, further studies are needed
to examine the effects of HP1β loss on lincRNAs in
ESCs and the role of potential HP1β–RNA complexes
on pluripotency.
The diffuse localization of HP1β in undifferentiated
ESCs remains particularly intriguing, especially since
H3K9me3 and HP1α foci are clearly visible [2, 13]. This
rules out the possibility that the diffuse localization of
HP1β is due to the absence of pericentromeric foci in
ESCs, and suggests that HP1β has a differential affinity
for H3K9me3 in ESCs versus differentiated cells [68].
This may reflect the preferential binding of HP1β to
another histone modification that prevents or competes
for its binding to H3K9me3, or else, possibly, competition
for HP1β between RNA and H3K9me3-containing nucle-
osomes. We can rule out a role for H3S10 phosphoryl-
ation in this phenomenon, as we see no differences in
H3S10P in ESCs and MEFs (data not shown). We do not
rule out, however, that other histone modifications that
are differentially abundant in pluripotent and differenti-
ated cells might impact HP1β localization [69–71]. HP1β
in vivo undergoes multiple post-translational modifica-
tions, including acetylation, phosphorylation, methylation,
and many more [72], and several of these modifications
have been correlated with the different functions of HP1
[21, 73–75]. Thus, HP1β itself could be differentially
modified in pluripotent and differentiated cells. Alterna-
tively, in order to explain HP1β diffuse localization in
ESCs, HP1β may be targeted to sites of action by binding
differentially to KAP1/TRIM28/TIF1β [76] in pluripo-
tent versus differentiated cells, although this interaction
was not detected under our LC-MS/MS experimental
conditions.
Our findings suggest that HP1β has distinct inter-
action partners in ESCs compared with differentiated
MEFs. In MEFs, HP1β interacting partners could be
classified into the following categories: ‘cell structure
and motility’, including actin, myosin, lamin, and other
filaments; ‘protein biosynthesis’, including mostly riboso-
mal proteins; ‘chromatin and nucleotide’; and ‘RNA pro-
cessing’ (Additional file 4). Based on these findings, we
speculate that HP1β association with nuclear filaments
such as lamin, myosin, and/or tubulin may contribute to
its association with stable heterochromatic foci in differ-
entiated cells (MEFs). The interaction of HP1β with an
RNA-processing protein category also led us to wonder
whether this category of proteins could be involved in
the silencing function of HP1β in differentiated cells. In
addition to the conventional mechanism of transcrip-
tional repression by heterochromatin, we propose that
HP1β and RNA-processing proteins could serve to
recognize RNA transcribed from heterochromatin, leading
to its sequestration and/or degradation. Such a role has
been reported for the HP1Swi6 protein in fission yeast [77].
In addition, association between Drosophila HP1a and a
broad set of repetitive RNAs has been recently reported
[78], and interactions between HP1a, RNA transcripts,
and some RNA-processing heterogeneous nuclear ribo-
nucleoproteins (hnRNPs) were also shown to be involved
in regulation of gene expression and heterochromatin
formation [79].
Conclusions
We propose that HP1β has two distinct roles in chro-
matin modulation that depend on the differentiation
state of the cell. Functionally, we found that HP1β is
required to maintain the undifferentiated/pluripotent
ESC state, whereas differentiated cells, such as EBs or
MEFs, fail to maintain a proper differentiation state in
the absence of HP1β, and reprogram into iPSCs more
easily than WT cells. These distinct functional roles of
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HP1β are manifest in our findings that HP1β has differ-
ent protein levels, nuclear distributions, binding sites
on chromatin, and protein binding partners at different
stages of differentiation. Future work will define the
mode of action with respect to the maintenance of
pluripotency as well as the role of HP1β in stabilizing
differentiated states.
Materials and methods
Cells and cell culture
Mouse ESCs, including R1, E14, HP1α−/−, HP1β−/−, their
WT littermate control line HM1 [52], iPSC lines Rr5 [14],
and WT, HP1α−/−, and HP1β−/− iPSCs (this study) were
cultured in 5 % CO2 at 37 °C on gelatin-coated dishes and
mitomycin-C treated MEF feeder layer in standard ESC
media Dulbecco’s modified Eagle medium (DMEM) con-
taining 10 % ESC-qualified fetal calf serum (FCS), 1000
U/ml LIF, 0.1 mM nonessential amino acids, 1 mM so-
dium pyruvate, 2 mM L-glutamine, 50 μg/ml penicillin-
streptomycin, 100 μM β-mercaptoethanol). All cell culture
reagents were purchased from GIBCO-BRL (Invitrogen,
Carlsbad, CA, USA). Primary MEFs, derived from embryos
at E13.5, were grown in DMEM containing 10 % FCS,
2 mM L-glutamine and 50 μg/ml penicillin-streptomycin.
MEFs (WT, HP1α−/−, HP1β−/−) which were used to gener-
ated iPSCs were derived from embryos of the correspond-
ing genotypes [34, 52].
Immunofluorescence and antibodies
Cells were plated on round sterilized 12 mm coverslips in
24-well culture plates (Greiner), coated with gelatin and
pre-plated with mitomycin-C treated MEFs. Cells were
fixed in 4 % paraformaldehyde for 15 min at room
temperature, washed twice with phosphate-buffered saline
(PBS) and permeabilized with 0.5 % Triton-X for 5 min at
room temperature, washed three times with PBS, and
blocked for 30 min with 10 % FCS in PBS at room
temperature. Primary antibodies (overnight at 4 °C) in-
cluded Nanog (R&D, AF2729; 1:20), HP1α (Euromedex,
2HP-1H5-As; 1:750), HP1β (Euromedex, 1MOD-1A9;
1:1750), HP1γ (Euromedex, 2MOD-1G6; 1:750) and
H3K9me3 (rabbit polyclonal kindly provided by T.
Jenuwein; 1:100). Detection was with anti-rabbit or
anti-mouse conjugated to Cy3 or anti-Donkey-FITC
(Jackson ImmunoResearch). Images were taken at 60×
with an oil NA1.4 lens using a spinning disk confocal
microscope (CSUX, Yokogawa, Japan) equipped with
an iXon + DU-897-BV monochrome EMCCD camera
(Andor, UK) mounted on an Olympus IX81 fully auto-
mated microscope, or with an Olympus IX71 epifluores-
cent microscope equipped with a Dp71 camera (Olympus).
Image analysis
Image analysis was performed as previously described
[14]. Fluorescence intensity was measured in confocal sec-
tions where each nucleus was at its optimal focal plane
and clearly distinguishable from surrounding nuclei in the
Z-stack using ImageJ [80]. Intensity and nuclear size were
measured in a semi-automated manner. Heterochroma-
tin foci were also measured in a semi-automatic man-
ner using the ‘analyze particles function’ in the ImageJ
software.
ESC differentiation
For EBs, R1 ESCs were cultured in suspension in Petri
dishes in standard ESC media without LIF. For NPC dif-
ferentiation, ESCs were separated from MEFs and grown
in suspension on Petri dishes without LIF for 4 days to
allow for EB formation. EBs were replated on polylor-
nithine/fibronectin (Sigma) coated eight-well μ-Slides
(ibidi, Munich, Germany) in DMEM/F12 medium sup-
plemented with ITS (5 mg/ml insulin, 50 mg/ml transfer-
rin, 30 nM selenium chloride) and fibronectin (5 mg/ml)
and grown for 2–6 days longer until NPC day 6–10,
respectively. The antibodies used to immunostain NPCs
included anti-Tuj1 (MAB1637, 1:200) and anti-Nestin
(#130, 1:100), a generous gift from Dr. Ron McKay.
Teratoma formation
Teratomas were produced as previously described [14].
Briefly, 106 ESCs were suspended in 35 μl ESC medium
and 15 μl Matrigel™ (BD Biosciences). This mix was
injected subcutaneously into the dorsal flank of SCID
mice (C.B-17/lcrHsd-SCID-bg). Three weeks after the
injection, teratomas were surgically dissected. Samples
were weighed, fixed in PBS containing 4 % paraformal-
dehyde, and embedded in paraffin. Sections were stained
with hematoxylin and eosin. The joint ethics committee
(IACUC) of the Hebrew University and Hadassah Medical
Center approved the study protocol for animal welfare.
The Hebrew University is an AAALAC International
accredited institute. All animal experiments were con-
ducted in accordance with the Hebrew University’s animal
committee, ethical approval number IACUC:NS-09-
11616-4.
Cell fractionation and immunoblots
Protein fractionation in the chromatin-bound, the nucleo-
plasmic or the cytoplasmic compartments was performed
essentially as described [81]. The protein extraction was
performed on 4 × 107 primary MEFs (passage 3) or on 4 ×
107 R1 mouse ESCs. The protein fractions were separated
on 4–20 % gradient Bis-Tris SDS gels (BioRad), blotted,
and incubated with the following primary antibodies:
HP1β (1MOD-1A9, Euromedex; 1:2000), HP1γ (2MOD-
1G6, Euromedex; 1:2000), H3K9me3 (rabbit polyclonal;
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1:100), kindly provided by T. Jenuwein (Freiburg), histone
H3, kindly provided by M. Bustin (1:10,000, rabbit), and
alpha tubulin (#ACLX135B, Accurate Chemical & Scien-
tific Corporation). Other antibodies used for western
blots included lamin A/C (sc-20680, SantaCruz; 1:100),
hnRNPa2/b1 (ab31645, Abcam; 1:200), phosphoserine
(ab9332, Abcam; 1:100) and phosphothreonine (Cell
Signaling #93865; 1:3000).
Cell proliferation assay
ESCs were plated at similar conditions and passage num-
ber at a density of 2.5 × 105 cells per 10 cm plate, and
counted in triplicates after 24, 48 and 96 h of culture.
The cell proliferation assay shown in Additional file 8
was performed similarly but in 12-well plates with 105
cells initially plated.
Magnetic cell separation based on SSEA1 expression
Magnetic separation was done according to Miltenyi
Biotec instructions using anti-SSEA-1 (CD15) microbe-
ads (130-094-530). We confirmed a homogeneous cell
population by obtaining small HP1β−/− ESC colonies
following plating of the sorted SSEA-1-positive cells.
Microarrays and data analysis
Microarray analysis was performed with Affymetrix Exon
Arrays MoEx-1_0-st-v1, with RNA purified from ESCs
and EBs using the RNeasy Mini Kit (Qiagen) supple-
mented with DNaseI. Two biological samples of each cell
type were analyzed: ES HM1 WT, ES HP1α KO or ES
HP1β KO, and the derived EBs HM1 WT, EBs HP1α KO,
or EBs HP1β KO. Quality and the comparability of the
datasets were verified with the Affymetrix Expression
Console software. Datasets in duplicate were compared
with their WT counterparts and only genes that were ei-
ther upregulated or downregulated in pairwise compari-
sons were selected for further analyses. A gene was
considered differentially expressed only if the detected sig-
nal was above the background (>45) in at least one of the
compared samples. The expression data files are available
from the Gene Expression Omnibus (GEO) database
[GEO:GSE65121].
Reverse transcription-PCR
Total RNA was purified using RNeasy Mini Kit (Qiagen).
Two micrograms of RNA treated with DNase I (Qiagen)
were reverse-transcribed using a high capacity reverse
transcriptase kit (Applied Biosystems) according to the
manufacturer’s instructions. qRT-PCR was done with
Power SYBR® Green PCR Master Mix (Applied Biosys-
tems) using the Bio-Rad CFX96 real-time system and























Data were normalized to GAPDH control. Agreement
between the fold changes found in qRT-PCR and in the
microarray analysis was calculated as r2 using the trend-
line option in Excel.
ChIP-qPCR for macro-satellites
ChIP was performed as previously described with a few
modifications [82, 83]. Briefly, chromatin solution from
R1 ESCs and MEFs was pre-cleared with a protein G-
agarose 50 % gel slurry (SC-2002) for 45 min at 4 °C and
immunoprecipitated overnight at 4 °C using the following
antibodies: mouse anti-HP1β (Euromodex-1 MOD-1A9-
AS; 2 μg), and the control mouse anti-IgG (Sigma I5381;
2 μg). Real-time PCR (Applied Biosystems) reactions were
performed in triplicate. The primers used in order to
assess the transcriptional level of the major satellites




The nuclear (S3 and P3) fractions of 108 MEF or R1
ESCs were used as extracts for immunoprecipitation.
Immunoprecipitations were done using antibodies for
HP1β (1MOD-1A9, Euromedex) and GFP (#11814460001,
Roche; negative control). Protein G-Agarose beads (Roche
Applied Science) were washed extensively with wash buf-
fer (30 mM Tris–HCl pH 7.5, 0.2 mM EDTA, 0.5 mM
dithiothreitol, 0.2 % Triton X-100, 150 mM NaCl), centri-
fuged on a 30 % sucrose cushion and washed with 30 mM
Tris pH 7.5. The bound proteins were subjected in part to
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SDS-PAGE silver staining and western blots and analyzed
using LC-MS/MS.
LC-MS/MS
Gel pieces were de-stained and proteins were reduced
by dithiothreitol (DTT) and alkylated by iodoacetamide
(IAA). Tryptic digestion was performed using porcine
trypsin (Sequencing Grade Modified, Promega, WI,
USA) overnight. The tryptic peptides were extracted by
5 % formic acid in 50 % acetonitrile and vacuum dried
by speedvac. Each dried fraction was reconstituted in
10 μl of 0.1 % formic acid and analyzed on a Dionex Ul-
timate 3000 RSLCnano system coupled to a LTQ-FT
Ultra mass spectrometer (Thermo Electron, Bremen,
Germany). The peptide separation was performed in a
capillary column (75 μm inner diameter × 15 cm) packed
with C18 AQ (5 μm particles, 300 Å pore size; Michrom
Bioresources, Auburn, CA, USA). Mobile phase A (0.1 %
formic acid in water) and mobile phase B (0.1 % formic
acid in acetonitrile) were used to establish a 90-min gra-
dient comprising 3 min of 0–5 % B and then 52 min of
5–25 % B followed by 19 min of 25–80 % B, mainten-
ance at 80 % B for 8 min, and finally re-equilibration at
5 % B for 8 min. The HPLC system was operated at a con-
stant flow rate of 300 nL/min. The sample was injected
into an LTQ-FT through an ADVANCE CaptiveSpray
source (Michrom Bioresources) with an electrospray
potential of 1.5 kV. The gas flow was set at 2, ion trans-
fer tube temperature was 180 °C, and collision gas
pressure was 0.85 millitorr. The LTQ-FT was set to
perform data acquisition in the positive ion mode as
described previously [85]. Proteins were identified by
Mascot search against the IPI_mouse database, as de-
scribed previously [85]. The list of significant protein
hits from the co-immunoprecipitation samples was
compared with the negative control samples. Proteins
found in control samples were excluded.
Reprogramming experiments
Reprogramming was conducted with a third generation
lenti-vector EF1α-STEMCCA that expresses a single
multicistronic transcript of the four factors (Oct4, Klf4,
Sox2, and c-Myc) [86]. 293-T cells in a 14-cm culture
dish of 70 % confluency were transfected with 5-plasmid
system using Trans-IT transfection reagent (Mirus).
Primary MEFs at passage 4 were seeded at 2 × 105 cells
per 10 cm dish. Virus-containing supernatants derived
from the 293-T culture 48 and 72 h after transduction
were filtered through a 0.45 μm cellulose acetate filter
and supplemented with 4 μg/ml polybrene. Each culture
of primary MEFs had two rounds of overnight infection
with virus/polybrene-containing supernatants diluted
1:10 in MEF medium. After infection, the cells were
washed with PBS and MEF medium for 2 days. On day
2, cells were re-plated on gelatin coated six-well plates
on top of mitomycin-C-treated MEFs in standard ESC
media. iPSC clones were selected according to their
morphology on day 12.
Knockdown experiments
For HP1γ knockdown, 105 cells per well were seeded in
12-well plates on a feeder layer of MEFs. Three differ-
ent conditions were used in the assay: no treatment,
siControl (Dharmacon, ON-TARGETplus Non-targeting
Control Pool), and siHP1γ (ON-TARGET plus Mouse
Cbx3 siRNA SMARTpool: L-044218-01-0005). siRNAs
were transfected at 50 nM final concentration using lipo-
fectamine 2000 (Life Technologies). Cells were counted
every 24 h using an automated cell counter (TC10, Bio-
Rad). HP1β knockdown in R1 ESCs was performed using
siGENOME siRNAs (Dharmacon) with Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instruc-
tions along with a scrambled control. Cells were grown
for an additional 48 h before cell fixation.
ChIP-Seq
ChIP-Seq experiments were performed on E14 ESCs from
129P2/Ola mice [87]. For each sample, 106 cells were
crosslinked with 1 % formaldehyde and cell nuclei were
prepared using swelling buffer (25 mM HEPES, pH 7.8,
1 mM MgCl2, 10 mM KCl, 0.1 % NP-40, 1 mM DTT).
Chromatin was sheared to 220 bp fragments. After IgG
preclearance the sheared chromatin was incubated with
4 μg of HP1β (Euromedex, 1MOD-1A9-AS) antibody
overnight. After washes with sonication buffer (10 mM
Tris–HCl, pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 % N-
lauroylsarcosine, 0.1 % Na-deoxycholate), high-salt-buffer
(50 mM HEPES pH 7.9, 500 mM NaCl, 1 mM EDTA, 1 %
Triton X-100, 0.1 % Na-deoxycholate, 0.1 % SDS), lithium
buffer (20 mM Tris–HCl pH 8.0, 1 mM EDTA, 250 mM
LiCl, 0.5 % NP-40, 0.5 % Na-deoxycholate) and 10 mM
Tris–HCl, chromatin was eluted from the protein G mag-
netic beads and the crosslink was reversed overnight.
After RNase A and proteinase K digestion, DNA was puri-
fied and cloned in a barcoded sequencing library for the
Illumina HiSeq2000 sequencing platform (single reads of
50 bp length).
ChIP-Seq data analysis
Data analysis was performed as previously described
[65]. HP1β Chip-Seq reads were aligned to the mouse
genome (mm9) using Bowtie [88], taking only uniquely
aligned reads with no more than one mismatch. Peaks
were extracted using MACS 1.4 [89], setting a minimal
p value cutoff of 10−3 and a fold change range for a model
building between 8 and 30. HP1β was considered to be as-
sociated with a gene if the peak was within the gene body
or was considered to be associated with a promoter region
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if the peak was within 5 kb upstream of the transcription
start site. In order to assess the correlation of HP1β with
other proteins, the genome was binned into non-
intersecting intervals of 3000 bases long. We next checked
if peaks for a given protein can be found within the same
bin as the HP1β peaks by extracting the hyper geometric
p value (Bonferroni corrected).
Data availability
The ChIP-Seq and microarray data are available from the
GEO database (accession number [GEO:GSE65122], which
groups our ChIP-Seq [GEO:GSE64946] and expression
[GEO:GSE65121] data). Microscopic original data are
available from the Dryad Digital Repository [90].
Additional files
Additional file 1: Figure S1. Validation of knockout cells. a
Immunostaining with HP1α and HP1β antibodies on WT, HP1α KO, and
HP1β KO ESC colonies surrounded by MEFs (examples are marked by
asterisks) as feeder layer. ESC colonies not easily detectable are marked
with a dashed line. Scale bars = 25 μm. b Western blots for HP1β in WT
and HP1β KO ESCs and EBs. c Co-staining with H3K9me3 antibody and
DAPI in WT, HP1α KO, and HP1β KO ESC colonies surrounded by MEFs
as a feeder layer. ESC colonies are marked with a dashed line. Scale
bars = 14 μm. The DAPI staining and H3K9me3 foci allow visualization
of the global DNA organization and chromocenter organization. d
Fluorescence recovery after photobleaching (FRAP) analysis of histone
H1 fused to GFP in WT and HP1β KO ESCs (n = 10). (PDF 5.30 mb)
Additional file 2: Figure S2. Mitosis in WT, HP1α KO, and HP1β KO
ESCs. a Confocal images of single mitotic nucleus of WT ESCs (top), HP1α
KO ESCs (middle), and HP1β KO ESCs (bottom) in metaphase or anaphase
immunostained for H3K9me3 (red) and counterstained with DAPI (blue).
The merged images shown on the left allow visualization of the DNA and
H3K9me3 distribution during metaphase and chromosome segregation
in anaphase. Scale bars = 7 μm. b HP1β knockdown experiment (siRNA)
in R1 ESCs. Cells were treated with control siRNA or HP1β siRNA and
grown for an additional 48 h before cell fixation and immunostaining
with HP1β, Nestin, and DAPI. (PDF 2.41 mb)
Additional file 3: Figure S3. Microarray validation. a The distribution of
the frequency of the fold change of the expression of genes from WT
versus HP1β KO ESCs. The curve represents the cumulative percentage,
which enables determination of the fold changes which are statistically
significant. P values corresponding to 0.05 and 0.005 are shown (light
squares). b Expression levels, measured by RT-qPCR, of nine representative
genes shown next to the corresponding microarray results for HP1α KO
(white) and HP1β KO (left) ESCs. The linear regression and correlation
were calculated between the two data sets (r = 0.8). c Same as in (b) with
the EB samples derived from WT, HP1α KO, and HP1β KO EBs.
(PDF 152 kb)
Additional file 4: Table S1. HP1β interacting partners in ESCs and
MEFs by co-immunoprecipitation followed by LC-MS/MS analysis. Only
proteins that were not identified in the corresponding control co-
immunoprecipitation samples were regarded as specific. Hits found in
both biological duplicates are in bold and underlined and are shown at
the top. The eight proteins that were identified in both cell types are in
bold and underlined and are shown at the bottom. Hits found also in
negative control experiments similar to our experimental settings in the
Contaminant Repository for Affinity Purification through its web interface
[91] are most probably false negative interacting partners, and thus were
excluded from the final list (Fig. 4a). Those few additional excluded hits
are marked by an asterisk in the lists and are in gray and italics. (Control
sets: CC76 CC78 CC79 CC80 CC81 CC82 with the following filters: Cell
type-HEK293, Affitnity Support-Agaraose beads, Instrument Type for Mass
Spectometry- LTQ-FT.) The HP1β interacting partners in MEFs were classified
according to their functional annotation and biological process using Gene
Ontology (GO). Only the different categories found to be statistically
significant are indicated by colors and found in the legend of the pie chart
on the right side of the excel sheet “HP1beta interactors MEF”. (XLSX 27.1 kb)
Additional file 5: Figure S4. HP1β is highly expressed in ESCs. a Western
blot for HP1β (top panel) and histone (H3, middle panel) in MEFs and mouse
ESCs (R1). For both cell types, the two nuclear fractions that include the
whole amount of HP1β and histone H3 (S3 nucleoplasmic fraction, P3
chromatin-bound fraction) are shown. Protein staining with PonceauS
(bottom panel) of the blot was used as a loading control. b Total HP1β
levels (S3 + P3) were quantified in MEFs versus ESCs from three western
blot experiments and normalized to H3 levels; error bars represent
standard error of the mean. c Western blot for HP1β in ESCs (R1) and
embryoid bodies (EBs) after 7 days of differentiation. Protein staining
with PonceauS in the HP1 range of the blot was used as a loading
control. d Global view of the expression level of CBX1/HP1β in human
pluripotent cells (hESCs and hIPSCs) and in differentiated cells produced
by the Amazonia! tool from public human transcriptome datasets [56].
(PDF 255 kb)
Additional file 6: Figure S5. HP1β is diffuse in fully pluripotent cells.
a R1 ESC colonies surrounded by MEFs used as a feeder layer for the
ESCs and as a staining positive control were co-immunostained with
DAPI, Nanog, and HP1β. Images with long and short exposures are
shown for the HP1β staining. Scale bars = 25 μm. b R1 and E14 ESCs
were co-immunostained with Nanog and HP1β. The ESC colony in the
marked area is enlarged in the right panel. Scale bars = 25 μm. c Co-
immunostaining with H3K9me3 and HP1β. The R1 ESC colony (from Fig. 3)
is shown on the right for easier comparison. Scale bars = 25 μm. d Relative
levels of HP1γ transcripts (Cbx3) following siRNA treatment measured by
RT-qPCR. e, f Cell proliferation assays performed in triplicate in six-well
plates. The graphs show the number of WT ESCs (e) and HP1β KO ESCs
(f) treated with siRNA against HP1γ or control siRNA every 24 h. (PDF 190 kb)
Additional file 7: Video 1. HP1β is diffuse in nuclei of undifferentiated/
pluripotent murine cells and localizes in foci in the course of differentiation.
Time lapse spinning disk confocal video of ESCs expressing the
endogenous HP1β fused to mCherry induced to differentiate with 1 μM of
retinoic acid for 40 h (time scale in the right upper part of the video).
(AVI 16.5 mb)
Additional file 8: Figure S6. HP1β ChIP-Seq analysis. a Enriched
categories in Gene Ontology (GO) analysis performed for the HP1β-bound
genomic regions. b Correlation analysis of HP1β ChIP-Seq data with other
existing genome-wide datasets in mouse ESCs. c, d Correlation analysis of
the upregulated and downregulated genes in HP1β KO ESC samples
compared to WT, with HP1β-bound promoters or HP1β-bound gene
bodies in WT ESC samples. e List of downregulated and upregulated
genes in HP1β KO ESC samples which are also genomically bound by
HP1β in WT cells. (PDF 1.19 mb)
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